CRMD - CorMedix Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.56 0.14 (1.52%) 0.01 (0.1%) 0.02 (0.17%) 0.03 (0.26%) -0.06 (-0.63%) 0.18 (1.84%) 0.12 (1.25%) -0.1 (-1.04%)

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.29
Diluted EPS:
0.28
Basic P/E:
33.4655
Diluted P/E:
34.6607
RSI(14) 1m:
84.62
VWAP:
9.7
RVol:

Events

Period Kind Movement Occurred At

Related News